top of page

Press releases

Antiviral drug Codivir shows promising effect against COVID-19


Jerusalem Post

This September, we were featured in the Jerusalem Post, Israel’s most read English newspaper. The publication reviews our clinical trials, the promising results, and the impact Codivir may have on the global pandemic. Read the full article here:


Global Trend Monitor

We were featured in the Global Trend Monitor, a UAE-based business & lifestyle magazine! 
Read the interview with our founder & CEO
Zyon Ayni and find out how Zyon founded Code Pharma to develop ground-breaking medical solutions as well as the promising results of our clinical trials regarding Codivir, its safety and effectiveness.


Gulf Today

Read the latest feature of Code Pharma in Gulf Today and find out how Codivir was discovered, our successful Phase I results, and where we stand with the Phase II study and emergency approvals from several countries


Code Pharma announces limited fundraising round for internators

We're going for an IPO and are launching a limited fundraising round for professional investors! Please find all the necessary information in our latest press release

bottom of page